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9,412 patients (documented about route of access and procedure strategy) were evaluated
(STEMI, n6,798 and NSTEMI, n2,614).
Results: Based on baseline characteristics, the patients in TFI group (n7,607) were
older, more over-weighted, female patients, resuscitations before arrival, STEMI patients,
worse Killip class and MR grade. TRI group (n1,805) had lower in-hospital morbidities,
especially major bleedings and puncture site complications, ICU admission, inotropics
apply, all cause mortality and MACE at discharge and 1 month later. The post-TIMI flow
and success rate of PCI were not significantly different between two groups, however. In
multivariate analysis, type of myocardial infarction, inotropic apply, ICU admission and
all cause mortality were related to the route of access. In-hospital morbidities and MACE
at 1 month were not related to the route of access.
Conclusions: Patients of TRI group had showed less STEMI patients and lower all cause
mortality. The in-hospital morbidities and 1 month MACE of TRI were not different from
those of TFI, however. It requires prospective and randomized controlled trials to assess
clinical efficacy and in-hospital morbidities related to route of access for interventional
procedure adequately.
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Background: Despite the recommendations of a routine invasive strategy (RIS) over a
selective invasive strategy (SIS) in the most recent and previous clinical practice
guidelines for non-ST-segment elevation acute coronary syndrome (NSTE-ACS), data on
the implementation of these treatment strategies in clinical practice over a longer time
period is currently not available.
Methods: In SWEDEHEART, baseline, procedural characteristics and outcomes are
recorded of all patients undergoing PCI. The RIS was retrospectively defined as coronary
angiography (CAG) and subsequent revascularization)3 days after admission. The SIS
was defined as CAG later then 3 days or none at all. Event rates were estimated with the
Kaplan-Meier method.
Results: Between 1996 and 2007, 204,092 consecutive NSTE-ACS patients were
recorded in SWEDEHEART. The use of a RIS increased from 3.8% in 1996-1998 to
37.4% in 2005-2007. The largest absolute increase was observed in low-risk patients, as
indicated by the FIR risk score. The use of the SIS decreased from 96.2% in 1996-1998
to 62.5% in 2005-2007. In the total population, there was a gradual decrease in three-year
all-cause mortality, from 29.1% in 1996-1998 to 23.9% in 2005-2007. This was mainly
observed in patients undergoing a RIS.
Conclusions: In conclusion, there has been an increase in the use of a RIS in NSTE-ACS
patients over the course of 12 years in Sweden. absolute increase was mainly observed in
low-risk patients, while a similar relative increase was observed in all risk groups. There
was a decrease in 3-year mortality over the time course, but this was not observed in SIS
patients.
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Background: Despite advances in therapeutic strategies, cardiovascular disease is the
leading cause of death particularly among high-risk patients including those that present
with cardiogenic shock and those that sustain cardiac arrest (CA). The mortality rate
among patients undergoing primary angioplasty (PPCI) in the setting of CA and whether
the location where the patient sustains cardiac arrest influences the outcome is not known
in the contemporary era. Aims: The aim of this study is to describe the patient population
accepted for PPCI sustaining CA to determine in-hospital (I/H) mortality and to determine
whether the location where the patient experiences CA influences outcome.
Methods: Data were collected prospectively on all patients undergoing PPCI for ST
elevation myocardial infarction in the setting of CA to a large UK tertiary cardiac centre
between January 2006 and October 2011. All patients sustaining CA either pre-hospital
(before and after the arrival of ambulance), during PPCI, or at any stage during
hospitalisation were recorded.
Results: In total, 335 patients (mean age 62.5 years) sustained CA during the study
period. Of these, 317 (94.6%) had PPCI performed. 53 (15.8%) patients sustained CA
prior to ambulance arrival, the remainder occurred (282[84%]) either after the ambulance
arrived or in-hospital (emergency room, medical ward or catheter lab). There were more
patients with cardiogenic shock who sustained CA before ambulance arrival (38.5%). The
I/H mortality was 21.2% in the overall CA patients. Those sustaining CA before
ambulance arrival experienced the highest mortality 32.1% compared to those (19.1%)
that had CA after ambulance arrival, in-hospital and in the catheter lab (Odds Ratio 1.99,
95% Confidence Interval 1.04-3.8). Furthermore, patients experiencing asystole or
electromechanical dissociation were associated with increased I/H mortality compared to
those experiencing ventricular arrhythmias (OR 2.83; 95% CI 1.56-5.14).
Conclusions: The I/H mortality remains high among patients undergoing PPCI in the
setting of CA. The I/H mortality is particularly high among those that arrest prior to
ambulance arrival.
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Background: The use of simple clinical criteria are there still of interest in our daily
practice with the advent of new markers of severity? This is the question which we wanted
to answer by revisiting the Killip classification.
Methods: We analyzed data collected between June 06 and October 11 in the
“Observatoire Régional Breton sur l’Infarctus (ORBI)”, a prospective registry of all
patients admitted to an interventional cardiology centre of Brittany in the acute phase of
a STEMI, within 24 h of symptoms onset. Main clinical data are presented and intra
hospital outcome was compared regarding of the Killip class determined at admission.
Results: Among 4342 patients included in the ORBI registry, Killip 1, 2, 3 and 4
respectively represented 3821 (88%), 281 (6.4%), 94 (2.2%), and 146 (3.4%) patients.
Main clinical data are summarized in table 1. There is a significant relation between the
Killip class and the intra hospital mortality (respectively 104 (2.7%), 27 (9.6%), 18
(19.1%), and 73 (50%) for Killip 1, 2, 3 and 4, p0.001), the hospital length of stay
(6.63, 8.05, 9.16, and 7.67, p0.05) and the left ventricular systolic ejection
fraction at discharge (51.310, 44.111, 41.712, and 38.414, p0.05).
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nKillip class 1
Killip class
2
Killip class
3
Killip class
4
n3821 n281 n94 n146
Patients
Age (years) 61.7 13 70.0 13.2 69.1 12.4 69.5 13.1
Male 2995 (78.4%) 188 (66.9%) 70 (74.5%) 96 (65.8%)
Hypertension 1448 (38.0%) 148 (53.2%) 51 (54.3%) 75 (53.2%)
Diabetes 391 (10.5%) 45 (16.5%) 19 (20.2%) 25 (17.1%)
Current smoker 1469 (38.7%) 60 (21.7%) 29 (31.2%) 34 (23.3%)
Prior myocardial
infarction
260 (6.8%) 26 (9.3%) 14 (15.0%) 14 (9.6%)
STEMI
Anterior area 1576 (41.3%) 171 (61.1%) 54 (58.7%) 65 (44.8%)
Mean delay*
(minutes)
175 150 210 180 220 144 154 137
Thrombolysis
prior to
admission
638 (16.7%) 36 (12.8%) 10 (10.6%) 12 (8.2%)
Coronary
angioplasty
2734 (71.6%) 200 (71.2%) 68 (72.3%) 107 (73.3%)
3-vessels or left
main coronary
artery disease
621 (16.7%) 65 (24.3%) 32 (36.0%) 53 (41.4%)
Haemodynamic
at admission
Heart rate
(/min)
75.2 17 80.7 19 91.6 22 82.7 35
Systolic arterial
pressure
(mmHg)
133.8 25 127.8 27 122.1 29 88.3 28
Need for a
circulatory
assistance**
75 (1.9%) 21 (7.4%) 12 (12.7%) 61 (41.8%)
*“Mean delay” is mean delay between onset of symptoms and admission in the
interventional cardiology centre.
**“circulatory assistance is intra aortic balloon pump and/or extracorporeal life
support.
Conclusions: Killip classification is still relevant for prediction of intra hospital outcome,
notably intra hospital mortality.
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Background: The occurrence, correlation and clinical outcome of intra-procedural stent
thrombosis (IPST) in patients undergoing primary percutaneous coronary intervention
(PCI) in the setting of acute coronary syndromes (ACS) have not been previously
described.
Methods: This retrospective study comprised a review of 1901 consecutive ACS patients
who received primary PCI in our center during the period of January 2006 to January
2011. IPST was defined as new, reappearing or increased (compared to baseline)
thrombus within the deployed stent before the index PCI procedure was completed. All
angiograms were independently reviewed frame-by-frame for the incidence of IPST.
Patient demographics, coronary risk factors, follow-up visits, and all relevant information
were retrieved from the hospital database. Patients with and without IPST were compared
with respect to clinical characteristics, angiographic parameters and cardiac events at
1-year follow-up.
Results: Overall, there were 23 cases of IPST detected in the study cohort, thus, the
prevalence of IPST was 1.2% in this group. There were no significant differences in terms
of baseline clinical characteristics between the two groups. Patients with compared to
those without IPST had significantly more bifurcation lesions involved, and more
thrombus burden at baseline. IPST group compared to no IPST group had 100% more
major adverse events on 1-year follow-up (30.4% vs. 14.4%, P0.02).
Conclusions: IPST was a rare complication of PCI in the setting of ACS. It correlated
with a few procedural factors and was more likely to cause cardiac events during 1-year
follow-up.
Table. Clinical characteristics, angiographic parameters, and clinical event
rates comparing patients with vs. without IPST
Variable IPST (N23)
No IPST
(N1878) p value
Age 61.1 [53.2, 69.1] 60.5 [52.1, 70.0] 0.91
% Diabetes Mellitus (%) 21.7 (5/23) 20.2 (380/1878) 0.86
% Previous MI (%) 17.4 (4/23) 21.6 (405/1878) 0.63
% Previous PCI (%) 17.4 (4/23) 19.2 (361/1878) 0.82
Minimum Pre-PCI TIMI Flow 0.00 [0.00, 1.00] 2.00 [0.00, 3.00] .0001
# of Attempted Vessels 1.00 [1.00, 1.00] 1.00 [1.00, 1.00] 0.10
1 year composite MACE, % 30.4% (7) 14.4% (270) 0.02
IPST, intraprocedural stent thrombosis; MI, myocardial infarction; PCI,
percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction;
MACE, major adverse cardiac events
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Background: Primary angioplasty is the best reperfusion strategy in ST elevation
myocardial infarction (STEMI). Thrombus aspiration with different devices might add a
clinical benefit following the results of the TAPAS study although findings from the
recent INFUSE-AMI trial questions this statement. We sought to analyze the clinical
impact of the use of aspiration devices.
Methods: From a retrospective multicenter (16 hospitals) study that compared different
drug-eluting stents in the STEMI setting we have analyzed the clinical impact of the use
of thrombectomy. Patients were consecutively included. Demographic and clinical data
were collected and a systematic follow up was performed.
Results: A total of 734 patients were included. A thrombectomy device was used in 211
patients (29%). After two years follow up the survival free from death and myocardial
infarction (MI) was 95% in the group with thrombectomy vs. 87.2% in the group without
(p0.001) and the survival free from death, MI and TLR was 93% and 84.6%
respectively (p0.002). Definite plus probable thrombosis incidence was 1% in the group
with thrombectomy and 3.2% in the group without (p0.09). Thrombectomy turned out
to be an independent predictor of death and MI (HR 0.2 IC 95% 0.08-0.6; p0.002) as
well as an independent predictor of the combined end point of death, MI and TLR (HR
0.4 IC 95% 0.2-0.8: p0.02) in a Cox regression analysis. This benefit was independent
of the type of stent used.
Conclusions: The results of this multicenter retrospective registry show that the use of
thrombus aspiration devices in the primary angioplasty with DES was associated to better
clinical outcomes.
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